A detailed history of Larson Financial Group LLC transactions in Ocular Therapeutix, Inc stock. As of the latest transaction made, Larson Financial Group LLC holds 9 shares of OCUL stock, worth $102. This represents 0.0% of its overall portfolio holdings.

Number of Shares
9
Previous 8 12.5%
Holding current value
$102
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025

BUY
$9.09 - $13.6 $9 - $13
1 Added 12.5%
9 $0
Q2 2025

Aug 08, 2025

BUY
$6.02 - $9.46 $48 - $75
8 New
8 $0

Others Institutions Holding OCUL

About OCULAR THERAPEUTIX, INC


  • Ticker OCUL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,966,896
  • Market Cap $875M
  • Description
  • Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...
More about OCUL
Track This Portfolio

Track Larson Financial Group LLC Portfolio

Follow Larson Financial Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Larson Financial Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Larson Financial Group LLC with notifications on news.